TMCI (Treace Medical Concepts) Long-Term Debt: $56.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMCI Treace Medical Concepts Inc TMCI
68 GF Score
Price $4.79
GF Value $6.35
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Treace Medical Concepts Long-Term Debt?

Treace Medical Concepts TMCI +6.21% 68 Long-Term Debt is $56.0 Mil as of Jun. 2026. GuruFocus rates TMCI with a GF Score™ of 68/100 and a GF Value™ of $6.35 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Treace Medical Concepts's Long-Term Debt for the quarter that ended in Jun. 2026 was $56.0 Mil.

Treace Medical Concepts's quarterly Long-Term Debt increased from Dec. 2025 ($55.6 Mil) to Mar. 2026 ($55.8 Mil) and increased from Mar. 2026 ($55.8 Mil) to Jun. 2026 ($56.0 Mil).

Treace Medical Concepts's annual Long-Term Debt increased from Dec. 2023 ($53.0 Mil) to Dec. 2024 ($53.3 Mil) and increased from Dec. 2024 ($53.3 Mil) to Dec. 2025 ($55.6 Mil).

Treace Medical Concepts  (NAS:TMCI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Treace Medical Concepts Long-Term Debt Related Terms

Treace Medical Concepts Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Treace Medical Concepts's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Treace Medical Concepts Long-Term Debt Chart

Treace Medical Concepts Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 29.37 52.71 53.01 53.31 55.58

Treace Medical Concepts Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.45 53.53 55.58 55.82 56.04
TMCI
68GF Score
Treace Medical Concepts Inc TMCI
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $56.0 Mil mean?
Treace Medical Concepts (TMCI) has a Long-Term Debt of $56.0 Mil as of Jun. 2026.
Is Treace Medical Concepts' Long-Term Debt too high?
Treace Medical Concepts' current Long-Term Debt is $56.0 Mil. Overall, Treace Medical Concepts has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' Long-Term Debt compare to TLSI and SENS?
Treace Medical Concepts' Long-Term Debt of $56.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Treace Medical Concepts's current Long-Term Debt is $56.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.35, compared to a current price of $4.79 — trading 24.6% below its estimated fair value. The current Long-Term Debt is $56.0 Mil. Treace Medical Concepts' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current Long-Term Debt is $56.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Treace Medical Concepts (TMCI) Overvalued in 2026?

Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued. The current stock price of $4.79 is trading 24.6% below its estimated GF Value™ of $6.35. GuruFocus considers Treace Medical Concepts to be Modestly Undervalued.

Key valuation signals for TMCI:

  • Long-Term Debt: $56.0 Mil
  • GF Value™: $6.35 vs. price of $4.79 (24.6% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Treace Medical Concepts Business Description

Address 100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
68GF Score

Get the complete analysis for TMCI

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.79
Price
$6.35
GF Value